Research Type: Academic Literature

  • Medicare Negotiation: A “Too Little” or “Too Late” Framework for Drug Selection

    Medicare Negotiation: A “Too Little” or “Too Late” Framework for Drug Selection

  • Abandon Biosimilars as Biologics are Natural Monopolies

  • List Price, Net Price, and the Rebate Caught in the Middle

  • Expansion of the Medicare 340B Payment Program

  • The “Netflix Model” of Financing Hepatitis C Treatment

    The “Netflix Model” of Financing Hepatitis C Treatment

  • Cardiovascular Drugs Not Price Aligned with Value in US

  • Perspective on National Coverage Analysis of CAR-T Therapies

    Perspective on National Coverage Analysis of CAR-T Therapies

  • Spending On Prescription Drugs In The US: Where Does All The Money Go?

    Spending On Prescription Drugs In The US: Where Does All The Money Go?

  • Money-Back Guarantees for Expensive Drugs: Wolf’s Clothing but a Sheep Underneath

    Money-Back Guarantees for Expensive Drugs: Wolf’s Clothing but a Sheep Underneath

  • Association of Rebates in Part D with Patient OOP and Federal Spending

    Association of Rebates in Part D with Patient OOP and Federal Spending